Stockscreener 앱 받기
1.3648
2.34%
-0.0352
전일 마감가:
$1.40
열려 있는:
$1.41
하루 거래량:
2.41M
Relative Volume:
0.37
시가총액:
$464.58M
수익:
$4.47M
순이익/손실:
$-71.67M
주가수익비율:
-5.8878
EPS:
-0.2318
순현금흐름:
$-59.58M
1주 성능:
+10.26%
1개월 성능:
-3.04%
6개월 성능:
-3.04%
1년 성능:
+32.74%
1일 변동 폭
$1.36
$1.44
1주일 범위
$1.25
$1.44
52주 변동 폭
$0.98
$2.725
오큐젠 Stock (OCGN) Company Profile
명칭
Ocugen Inc
전화
484-328-4701
주소
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.37 | 474.75M | 4.47M | -71.67M | -59.58M | -0.2318 |
VRTX
Vertex Pharmaceuticals Inc
|
520.21 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
808.93 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
863.25 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.18 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
355.86 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
오큐젠 Stock (OCGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-17 | 개시 | Canaccord Genuity | Buy |
| 2026-03-11 | 개시 | Oppenheimer | Outperform |
| 2024-10-15 | 개시 | Maxim Group | Buy |
| 2023-03-01 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 개시 | Mizuho | Buy |
| 2022-06-15 | 재개 | ROTH Capital | Buy |
| 2022-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 개시 | Noble Capital Markets | Outperform |
| 2021-06-11 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
모두보기
오큐젠 주식(OCGN)의 최신 뉴스
Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch
Ocugen Inc. stock rises Tuesday, outperforms market - MarketWatch
Ocugen at Canaccord Genuity’s 46th Annual Growth Conference: late-stage push - Investing.com Canada
Research Analysts Issue Forecasts for Ocugen Q3 Earnings - MarketBeat
What is Noble Financial's Forecast for Ocugen Q3 Earnings? - MarketBeat
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
Hennion & Walsh Asset Management Inc. Purchases 1,553,672 Shares of Ocugen, Inc. $OCGN - MarketBeat
Ocugen (NASDAQ:OCGN) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
Ocugen's Q2 Earnings Miss Estimates as R&D Costs Rise, Stock Falls - Yahoo Finance
Ocugen Inc (OCGN) Stock News Today - TradingKey
State Street Corporation (NYSE: STT) reports 6.3% beneficial stake in Ocugen - stocktitan.net
Ocugen Q2 Earnings Call Highlights - MarketBeat
Ocugen (NASDAQ:OCGN) Posts Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Ocugen Inc (OCGN) (Q2 2026) Earnings Call Highlights: FDA Cleara - GuruFocus
Form 8K Ocugen, Inc For: 6 August By Investing.com - Investing.com South Africa
Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch
Ocugen, Inc. 2026: Revenue $1.49M, EPS ($0.07) — 10-Q Summary - TradingView
Ocugen (NASDAQ: OCGN) raises $112.5M via converts as losses hit $44.1M - Stock Titan
Ocugen, Inc. Announces Management Changes - marketscreener.com
Earnings call transcript: Ocugen posts Q2 2026 revenue beat as loss widens - Investing.com
OCGN: FDA cleared phase III for OCU410; cash runway extended to 2028 after $130M financing - TradingView
Ocugen Provides Business Update with Second Quarter 2026 Financial Results - Ocugen, Inc.
Ocugen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Ocugen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Ocugen reports $1.49M Q2 revenue, $0.07 loss per share and $100.4M cash as of June 30, 2026 - TradingView
Ocugen: Q2 Earnings Snapshot - marketscreener.com
Ocugen Reports Q2 2026 Results, Advances OCU410 Phase 3, Secures RMAT Designation and $130 Million Financing - quiverquant.com
Press Release: Ocugen Provides Business Update With Second Quarter 2026 Financial Results - Moomoo
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Ocugen Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Ocugen Inc (2H51.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ocugen Inc. stock falls Friday, underperforms market - MarketWatch
FDA grants OCU410 regenerative medicine advanced therapy designation for geographic atrophy - AllSci
Ocugen to Present Modifier Gene Therapy Platform at Upcoming August 2026 Investor Conferences - Quiver Quantitative
A one-time treatment for geographic atrophy gains FDA RMAT status - stocktitan.net
Ocugen Inc (OCGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OCGN|Ocugen Inc|Price:1.262|Chg%:+0.051 - TradingKey
Ocugen Inc (OCGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ocugen Inc (OCGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ocugen Inc (OCGN) Balance Sheet - TradingKey
Ocugen Inc (OCGN) Cash Flow - TradingKey
Ocugen Inc (OCGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ocugen Inc (OCGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ocugen Inc (OCGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future - Kavout | AI
Ocugen Inc (OCGN) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
OCGN|Ocugen Inc|Price:1.210|Chg%:-0.060 - TradingKey
Ocugen Inc (OCGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ocugen Inc (OCGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
오큐젠 (OCGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
오큐젠 주식 (OCGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zhang Junge | Director |
Apr 01 '26 |
Option Exercise |
0.79 |
194,134 |
154,303 |
1,359,316 |
0.00%
0.96%
자본화:
|
볼륨(24시간):